Details werden geladen...
NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum | The Manila Times
TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the 'Company” or 'NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today provided a business update highlighting key accomplishments during its second fiscal quarter ended March 31, 2026, as well as subsequent developments.
Ähnliche Seiten
EagleNXT Provides Shareholder Update as Second Quarter Momentum Builds Across Defense and Commercial Markets | The Manila Times
https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/eaglenxt-provides-shareholder-update-as-second-quarter-momentum-builds-across-defense-and-commercial-markets/2345303Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/indaptus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2344835Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout | The Manila Times
https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/plus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update-on-reyobiq-clinical-program-and-cnside-commercial-rollout/2345286Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/dare-bioscience-reports-first-quarter-2026-financial-results-and-provides-business-update/2344377Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/05/08/tmt-newswire/globenewswire/tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update/2339409